# Randomized Safety Study of CVT-301 Compared to an Observational Control Group

> **NCT02352363** · PHASE3 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 408 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** CVT-301
- **OTHER:** Observational cohort

## Key facts

- **NCT ID:** NCT02352363
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2019-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02352363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02352363, "Randomized Safety Study of CVT-301 Compared to an Observational Control Group". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02352363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*